Co-authored by Marni Sommer, DrPh, RN, of Columbia University Mailman School of Public Health, the report examines hematologic health across key stages of life. It highlights conditions that intersect with menstruation, reproductive health, pregnancy, and aging, emphasizing that these periods are not medical “side issues” but central drivers of morbidity.

A core theme is under-recognized heavy menstrual bleeding, which remains frequently underdiagnosed and stigmatized. The commission connects persistent symptoms to inadequate access to evidence-based care, leaving many people without effective management and with measurable impacts on physical health and daily quality of life.

The report also frames hematologic outcomes through social determinants. Poverty, limited healthcare access, and broader structural inequities are presented as modifiable contributors that shape who receives testing, appropriate referrals, and timely therapy.

The commission launches in tandem with the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, where thousands of experts convene to advance research and clinical practice in thrombosis and hemostasis. This timing underscores the report’s translational intent: to convert scientific insight into globally applicable standards of care.

ISTH’s expanding women’s health focus is reflected in the newly established ISTH Women’s Health Hub, a program designed to accelerate education, collaboration, and advocacy for bleeding and clotting disorders across every stage of a woman’s life. The commission’s publication aligns with broader momentum for sex- and gender-responsive hematology research.

A related Commentary by Sommer in The Lancet Haematology argues that menstrual health must be treated as a foundational component of population health. Without routine recognition of the menstrual cycle as a lifelong health issue, the report warns that meaningful improvements in access and outcomes will remain constrained.

Together, the commission and accompanying commentary present a call to action for clinicians, researchers, policymakers, and advocates to reduce preventable mortality and inequity. By prioritizing visibility, investment, and evidence generation in women’s hematologic care, the initiative aims to close gaps that have persisted for decades.

Subject of Research: Global female health and haematology (bleeding and clotting disorders across the life course)
Article Title: Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission
News Publication Date: July 16, 2026
Web References: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00079-7/abstract
References: DOI: 10.1016/S2352-3026(26)00079-7
Image Credits:

At its core, the WHO Global Code aimed to establish an ethically responsible framework whereby HICs would limit their aggressive recruitment of physicians from LMICs, countries often grappling with critical physician shortages. The rationale was that by reducing the brain drain, these shortage countries could retain a higher density of physicians, thereby improving access to care and contributing to the broader goal of global health equity. The Harvard Pilgrim Health Care Institute team employed a robust epidemiological approach, analyzing physician migration trends from 2000 to 2021 to OECD countries—a bloc predominantly comprising wealthy nations—comparing outcomes between 56 WHO-designated shortage countries and 116 non-shortage countries.

Findings reveal that the Code initially yielded promising results, with a marked short-term reduction in the annual emigration of physicians from shortage countries by about 2,600 per year. This amount equates to a nearly 30% decrease in physician outflow, translating to approximately 17,000 fewer doctors leaving shortage countries within the first five years post-implementation. This temporary decline underscores the potential of international policy frameworks to influence global health workforce mobility. Nevertheless, the study highlights that this effect was transient, fading over the subsequent years without resulting in a lasting improvement in physician density within shortage countries.

Physician density—calculated as the number of physicians per 10,000 population—is a critical metric for assessing health care accessibility and capacity. Despite the early reductions in migration, the data did not exhibit a significant increase in this measure over the full duration of the study. This stagnation suggests that curtailing migration alone is insufficient to build a sustainable physician workforce in shortage countries. The authors emphasize that systemic factors such as inadequate working conditions, limited training opportunities, and lack of institutional support play major roles in driving physicians to seek employment abroad.

Delving deeper into these systemic issues, the research advocates for comprehensive investments to strengthen local health systems in LMICs. This entails ramping up medical education capacity, enhancing health infrastructure, and improving the professional environment to retain talent. High-income countries and international organizations are encouraged to collaborate beyond policy restrictions on recruitment by contributing resources and expertise that address the root causes motivating physician migration. Such a multifaceted strategy is pivotal for fostering an environment where physicians can thrive and pursue meaningful careers in their home countries.

Senior author Hao Yu, associate professor of population medicine at Harvard Medical School, remarked on the policy implications, noting that while the Code serves as an important lever in reducing unethical recruitment practices, it must be complemented with broader, sustained efforts. The waning effect over time observed in the study reveals the limitations of policy without infrastructure and economic support. Tarun Ramesh, lead author and research fellow at the Harvard Pilgrim Health Care Institute, underlined the importance of improving working conditions and expanding training capacity to realize sustainable improvements in physician density.

This research contributes significantly to the discourse on global health equity by providing empirical evidence on the strengths and weaknesses of international governance mechanisms. It reinforces the WHO’s pivotal role in orchestrating policies that align national interests with global health objectives. The study implicitly warns against the detrimental consequences of disengagement from multilateral institutions like the WHO, which facilitate coordinated actions essential for addressing transnational health workforce challenges.

Moreover, the persistence of physician shortages despite policy interventions illuminates complexities embedded within global health systems, including the economic and social determinants that fuel migration. Physicians often migrate for better remuneration, career advancement, and improved quality of life—factors that policies prohibiting recruitment cannot rectify alone. Effective solutions must, therefore, integrate economic development and health sector strengthening, making retention an attractive and feasible choice for health professionals.

The study’s methodology, which involved comparing migration flows to OECD countries and dissecting data across 56 shortage and 116 non-shortage countries over a 21-year timeframe, offers a comprehensive and longitudinal perspective unmatched in previous analyses. This level of granularity enables a clear separation of short-term policy effects from long-term systemic trends, advancing the field’s understanding of health workforce dynamics.

Ultimately, while the 2010 WHO Global Code of Practice has demonstrated the capacity to influence international physician migration trajectories, the findings convey that policy alone is not a panacea. Global health stakeholders must adopt an integrated approach that combines ethical recruitment with strategic investments in health workforce development and supportive working environments. Only through such combined efforts can global disparities in health care capacity be effectively addressed to achieve equitable health outcomes worldwide.

The study sets a precedent for ongoing surveillance and evaluation of global health workforce policies, ensuring that efforts to mitigate physician brain drain are continuously refined in response to evolving challenges. It also invites countries, particularly those in the high-income bracket, to renew their commitment to global health solidarity by not only adhering to ethical recruitment standards but also playing an active role in fortifying health care systems in the nations most affected by shortages.

Subject of Research:
Article Title: Changes in Physician Emigration and Density after the 2010 WHO Global Code of Practice
News Publication Date: 6-Feb-2026
Web References: http://www.populationmedicine.org/
References: JAMA Health Forum, 6-Feb-2026
Keywords: Caregivers, Health disparity, Health equity, Doctor patient relationship, Health care costs, Health care delivery, Health care policy

The notion that poverty can be precisely addressed through algorithms and mathematical models has long influenced policy design. Yet, the rigors of real-world implementation continually expose the shortcomings of this approach. The study paints a vivid portrait of how reliance on mathematical poverty lines or income thresholds fails to capture the nuanced and multifaceted nature of indigence, particularly in settings burdened by social inequities, informal economies, and cultural complexities. Poverty’s deeply embedded social dimensions necessitate an expanded framework, one that acknowledges the fluidity of economic hardship and the limitations of purely numerical categorizations.

At the heart of the UHC indigent program lies the goal of extending healthcare access to the most vulnerable populations. However, the study’s findings demonstrate that the mechanisms used to identify eligible beneficiaries often miss critical groups due to the inadequacy of traditional poverty measures. Instead of systematically including all those in need, the program faced challenges of exclusion, social stigma, and bureaucratic hurdles, casting shadows over the idealistic vision of universal coverage. The critique is not merely technical but philosophical: it challenges the reduction of social suffering to statistical outputs.

The researchers employed a mixed-methods approach, combining quantitative data analysis with extensive qualitative fieldwork. Interviews with community members, healthcare workers, and policymakers revealed that local conceptions of poverty diverged significantly from the program’s eligibility criteria. Elements such as social exclusion, family dynamics, and the unpredictability of livelihood strategies were identified as critical factors affecting whether an individual was truly indigent. Such granular insights underline the limits of top-down identification tools that ignore local context and lived experiences.

One technical aspect of the study focused on the statistical tools used for beneficiary targeting, such as proxy means tests (PMTs) which estimate poverty status based on household asset ownership and observable characteristics. While PMTs offer an ostensibly objective method to identify the poor, the research exposes how their implementation can lead to systemic biases. For instance, households with fluctuating incomes or those engaged in informal labor often do not fall neatly into categories defined by the PMT, resulting in their exclusion. This misalignment points to a critical design flaw in siloed poverty measurement tools.

Furthermore, social stigma emerged as a pervasive barrier in the application of the program. Many eligible individuals were reluctant to self-identify as indigent due to shame or fear of social marginalization. This psychosocial dimension, often neglected in technical models, contributes significantly to under-enrollment and program inefficacy. The study argues for the integration of community sensitization processes and trust-building measures to counteract these negative effects, emphasizing that the social fabric must be woven into the programmatic response.

The bureaucratic complexity of the indigent identification process also surfaced as a major challenge. The multilayered verification procedures, aimed at minimizing fraud, inadvertently introduced delays and administrative burdens that disproportionately affected the poor. Long wait times, paperwork demands, and lack of transparency compounded the difficulties faced by indigent populations. This insight underscores the paradox that governance mechanisms, while designed to protect resources, may undermine social equity objectives if not calibrated carefully.

Another important technical takeaway highlights how the program’s reliance on static poverty metrics failed to adapt to dynamic socioeconomic realities. In Kenya, household economic status can fluctuate rapidly due to seasonal employment, health shocks, or environmental factors. The study suggests that beneficiary identification systems should incorporate temporal flexibility, allowing reevaluation and adjustments over time, rather than a one-time assessment. Enhancing system responsiveness could substantially improve coverage and inclusivity.

In linking these findings to broader theoretical frameworks, the researchers advocate for shifting from a technocratic view of poverty to a social constructivist perspective. Such an approach recognizes poverty as a relational and contextual phenomenon, shaped by structural inequalities, access to resources, and social networks. Transforming this understanding into policy design requires interdisciplinary collaboration, inclusive dialogue, and iterative feedback from affected communities.

The lessons drawn from Kenya’s experience resonate globally, urging policymakers to reconsider the prevailing reliance on quantitative poverty indicators in welfare programs. While tools like PMTs and poverty lines remain useful for broad assessments, their application at the individual beneficiary level needs critical reevaluation. The evidence calls for integrated frameworks that combine economic measures with social assessments, participatory decision-making, and local knowledge to genuinely identify and support the indigent.

Technologically, the findings open avenues for innovative solutions that leverage data science while respecting social complexity. Future programs might deploy hybrid models combining machine learning algorithms trained on diverse socioeconomic indicators alongside human-centered validation processes. Moreover, mobile technology and community-based platforms could facilitate continuous engagement and real-time monitoring, reducing bureaucratic overhead and enhancing trust.

Importantly, the study challenges narratives that frame poverty solutions as purely technical problems solvable by optimization algorithms. Instead, it reasserts poverty’s fundamentally social character, demanding policies that emphasize empathy, dignity, and social justice. Programs designed without this ethos risk perpetuating cycles of exclusion and inequality, undermining the fundamental premise of universal health coverage and social protection.

In conclusion, the examination of the UHC indigent program in Kenya provides a compelling case study reorienting poverty identification towards a socially informed paradigm. It calls on global health actors, governments, and development agencies to rethink beneficiary identification beyond numbers and embrace holistic, context-aware approaches. As nations grapple with expanding social services under resource constraints, this research reinforces that success hinges on recognizing poverty’s social dimensions and embedding that recognition into program design and implementation.

The implications extend far beyond Kenya’s borders. In an era marked by increasing inequality, pandemics, and climate shocks, accurately identifying the vulnerable is foundational to safeguarding health equity. This study marks a critical step in illuminating the path forward, emphasizing that poverty alleviation is not merely a technical challenge but a profound social mission requiring nuanced understanding, innovative thinking, and, above all, human compassion.

Subject of Research: Beneficiary identification challenges and lessons from the implementation of Kenya’s Universal Health Coverage indigent program, focusing on poverty as a social rather than purely mathematical issue.

Article Title: “Poverty is a social issue, not a mathematical problem”: examining the lessons for beneficiary identification from implementation of the UHC indigent program in Kenya.

Article References:
Maritim, B., Mbau, R., Musiega, A. et al. “Poverty is a social issue, not a mathematical problem”: examining the lessons for beneficiary identification from implementation of the UHC indigent program in Kenya. Int J Equity Health (2026). https://doi.org/10.1186/s12939-026-02767-5

Image Credits: AI Generated

HPV vaccination has long been hailed as a revolutionary tool in the fight against cervical cancer, which remains a leading cause of mortality among women globally. Prior to the pandemic, concerted efforts had led to incremental increases in vaccine coverage, particularly in high-income countries where healthcare infrastructure and access are more robust. However, the disruptions caused by COVID-19 have reversed much of this progress, exposing and exacerbating disparities that influence vaccine availability, acceptance, and policy implementation. Understanding these multilayered challenges is essential to forging an effective path forward.

One of the most significant barriers identified in the post-pandemic landscape is geopolitical disparity. The pandemic underscored vast inequalities in resource allocation, healthcare system resilience, and international cooperation. Countries in the Global South, already grappling with limited healthcare budgets and infrastructural deficits, now face increased competition for vaccine supplies and diminished capacity for public health campaigns. Moreover, shifting geopolitical alliances and the rise of vaccine nationalism have complicated collaborative efforts necessary for coordinated HPV vaccine dissemination, effectively sidelining vulnerable populations in low- and middle-income countries.

Beyond geopolitics, sociocultural factors have surfaced as equally formidable obstacles to achieving widespread HPV vaccine uptake. Vaccine hesitancy, fueled by misinformation, cultural beliefs, and historical mistrust of medical authorities, has surged in multiple regions. These hesitations, often entwined with gender norms and sexual health taboos, challenge the public health messaging critical for HPV vaccination campaigns. In some societies, vaccinating predominantly young girls against a sexually transmitted infection invites moral anxieties and stigmatization, creating an environment hostile to vaccine acceptance despite clear evidence of the vaccine’s safety and efficacy.

Ethical disparities constitute another layer of complexity in the post-COVID HPV vaccination discourse. The principles of justice and equity come into sharp focus when assessing who gains access to the vaccine and under what conditions. Ethical debates now extend to vaccine prioritization, consent, and autonomy, particularly among adolescents and marginalized communities. The pandemic’s strain on healthcare systems has led to difficult triage decisions, often disadvantaging preventive interventions like HPV vaccination in favor of acute COVID-19 care. This reality raises poignant questions about the value placed on long-term preventive healthcare in global health agendas.

Technically, the HPV vaccines themselves remain a marvel of biomedical innovation. Developed using recombinant DNA technology, these vaccines target the most oncogenic strains of HPV, primarily types 16 and 18, which account for approximately 70% of cervical cancer cases worldwide. Advances in vaccine formulations have extended coverage to additional strains, enhancing protective efficacy. Despite these advances, manufacturing bottlenecks and supply chain disruptions witnessed during the pandemic have impeded timely distribution. Cold chain requirements, although improved, continue to pose logistical hurdles, particularly in remote and resource-poor settings.

The vaccine’s mechanism of action involves eliciting a robust immune response against the HPV virus’s major capsid protein, L1, forming virus-like particles that prime the immune system without causing infection. This feature not only ensures safety but also durability of immune memory, reducing the need for frequent booster doses. Despite the vaccine’s biological strengths, deploying it on a global scale remains limited by structural and sociopolitical shortcomings, which modern public health frameworks must urgently address.

Amidst these challenges, some nations have pioneered innovative strategies to mitigate disparities. Integration of HPV vaccination into national immunization schedules, coupling vaccination with school-based health services, and harnessing digital health technologies for education and tracking have shown promising results. Yet, scaling these initiatives requires robust funding and political will, factors often undermined by competing post-pandemic recovery priorities. In parallel, international agencies like the World Health Organization and Gavi, the Vaccine Alliance, play critical roles in negotiating vaccine procurement and driving equity-focused policies, though their mandates are frequently constrained by geopolitical dynamics.

A further dimension unveiled by recent studies pertains to the broader ethical implications surrounding vaccine justice in a post-pandemic world. The concept of ‘vaccine equity’ transcends mere distribution; it encompasses respecting cultural identities, ensuring informed consent, and addressing systemic inequities ingrained in global health governance. The HPV vaccine, typically administered to adolescents, engages additional ethical concerns related to parental rights, adolescent autonomy, and informed decision-making, which vary significantly across cultures. Moving forward, ethical frameworks must adapt to accommodate such nuances, fostering respectful engagement and empowerment.

In addition, the intersectionality of health disparities emerges sharply in the context of HPV vaccination. Vulnerable populations—such as indigenous groups, refugees, and socioeconomically disadvantaged communities—often reside at the nexus of multiple inequities. These compounded vulnerabilities heighten their risk of both HPV-related diseases and barriers to vaccination. Tailored public health interventions that recognize and address intersectionality are critical for closing these gaps, demanding culturally competent and inclusive policy approaches unlike ever before.

The pandemic’s influence on global health narratives cannot be overstated. The sudden and overwhelming focus on COVID-19 has overshadowed essential preventive measures against diseases like HPV-related cancers. Global health funding landscapes have been realigned, with significant investments directed toward pandemic preparedness and vaccine development, leaving chronic disease prevention programs underfunded and neglected. This shift jeopardizes decades of progress and necessitates renewed advocacy for balanced resource allocation that integrates infectious disease control with long-term cancer prevention goals.

Crucially, the role of misinformation, accelerated by social media platforms, presents a daunting challenge to HPV vaccine acceptance. Anti-vaccine rhetoric, conspiracy theories, and pseudoscientific narratives have gained traction, sowing distrust and confusion across diverse populations. Addressing this “infodemic” requires strategic communication efforts that combine scientific rigor with empathetic community engagement. Public health campaigns must evolve to counteract digital misinformation, leveraging influencers, educators, and local leaders to rebuild trust and promote vaccine literacy effectively.

In light of these multifaceted challenges, a recalibrated approach to HPV vaccination strategies is imperative. Policymakers, healthcare providers, and global health actors must synergize efforts to dismantle geopolitical barriers, integrate sociocultural sensibilities, and uphold ethical imperatives. This holistic framework demands investment in health infrastructure, transparent governance, and multisectoral collaborations that extend beyond biomedical solutions to encompass social determinants influencing health outcomes.

Moreover, innovations in vaccine technology offer promising avenues for overcoming existing limitations. Advances in thermostable vaccine formulations could relax cold chain dependencies, while single-dose regimens under investigation have the potential to simplify delivery logistics. Leveraging digital health for real-time data monitoring and personalized outreach can optimize immunization coverage and follow-up. However, technology is only as effective as the systems and environments into which it is introduced, underscoring the need for comprehensive capacity building at local and national levels.

The post-COVID era also presents a unique opportunity to revitalize global health priorities, emphasizing resilience and equity. Lessons learned from the pandemic’s impact on vaccination programs underscore the vital importance of preparedness, flexible health systems, and equitable access. The HPV vaccine’s role within this paradigm exemplifies the intertwined nature of infectious disease control and chronic disease prevention, calling for integrated health strategies that safeguard and advance population health holistically.

As the world stands on the cusp of renewed hope and considerable uncertainty, the pathway to equitable HPV vaccination encapsulates broader themes of justice, science, and solidarity. The imperative is clear: to transcend geopolitical rivalries, respect and incorporate diverse cultural contexts, and embed ethical principles at the core of public health endeavors. Achieving widespread HPV vaccination is not merely a medical goal but a testament to our collective commitment to protecting future generations from preventable cancers and advancing the ideal of health equity worldwide.

Subject of Research: Post-COVID disparities affecting global HPV vaccination programs in geopolitical, sociocultural, and ethical contexts.

Article Title: Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.

Article References:
Sad, S., Iftikhar, L. & Chamout, M. Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health. Int J Equity Health 24, 308 (2025). https://doi.org/10.1186/s12939-025-02669-y

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12939-025-02669-y

Healthcare access is a complex construct influenced by numerous interdependent determinants, including affordability, availability, acceptability, and accommodation of services. Until now, the precise measurement of access barriers has been elusive due to the absence of a standardized, reliable, and valid instrument. The newly developed HABS addresses this gap by integrating rigorous psychometric methodologies with comprehensive content derived from patient-centered and health systems frameworks. Thus, HABS enables researchers and policymakers to dissect how particular barriers influence different populations, fostering tailored interventions.

The validation process of HABS employed a large, diverse sample representing varying socio-demographic backgrounds and clinical conditions. Through exploratory and confirmatory factor analyses, the scale’s structure was refined to capture distinct yet interconnected dimensions of access barriers, including financial constraints, transportation difficulties, perceived discrimination, and communication challenges with providers. This multidimensional approach ensures a nuanced understanding that surpasses simplistic one-dimensional measures.

Technically, HABS consists of carefully calibrated items scored on Likert scales, allowing for quantification of the intensity of access barriers. Advanced statistical techniques ensured high internal consistency, test-retest reliability, and construct validity. Moreover, convergent validity was established through correlations with established health outcome indicators, confirming that heightened barriers detected by HABS align with poorer health metrics.

One of HABS’s unique strengths lies in its adaptability across diverse healthcare settings. The researchers demonstrated its applicability not only in urban tertiary care centers but also in rural and underserved communities where access obstacles are often compounded by infrastructure deficits. This broad utility signals the tool’s potential for widespread adoption in both low-resource and developed healthcare environments.

Importantly, the HABS framework transcends mere assessment by providing actionable insights. Health systems can deploy the scale to monitor access barriers dynamically and evaluate the effectiveness of policy interventions aimed at reducing inequities. For instance, the quantifiable data yielded by HABS can guide resource allocation decisions, identify priority areas needing infrastructure improvements, or enhance culturally competent care initiatives.

The development of HABS is underpinned by an interdisciplinary approach incorporating perspectives from public health, sociology, behavioral science, and health services research. This comprehensive conceptual synthesis ensures that the scale not only measures tangible obstacles but also captures the subjective experiences shaping patients’ healthcare navigation and decision-making processes.

In the context of the ongoing global push for Universal Health Coverage (UHC), HABS offers a practical tool to operationalize equitable access monitoring, a key component often referenced in international health agendas. By enabling more precise diagnostics of access failures, the scale supports accountability frameworks and the tracking of progress toward UHC targets.

Notably, the scale’s introduction arrives alongside growing awareness of healthcare disparities exacerbated by the COVID-19 pandemic, which has exposed vulnerabilities in many health systems. The HABS can help elucidate how pandemic-related disruptions have differentially impacted access for marginalized communities, thereby informing recovery strategies that prioritize equity.

While the initial validation study reports promising psychometric properties, the authors acknowledge the need for ongoing validation across additional cultural and linguistic contexts to enhance the scale’s generalizability. They advocate for future research to refine and adapt HABS for pediatric, geriatric, and specialty care settings, reflecting diverse healthcare utilization patterns.

Technological integration is another exciting frontier for HABS utility. Embedding the scale within electronic health records (EHR) or mobile health applications could facilitate real-time barrier assessments, allowing frontline providers to tailor care plans responsively. This would mark a significant step toward personalized equity in health service delivery.

Moreover, the open-access dissemination strategy embraced by the developers permits researchers globally to apply and improve HABS without restrictive licensing barriers. This democratization of measurement tools aligns with the ethical imperative to promote transparency and inclusivity in health equity research.

The introduction of HABS has already begun to stimulate interest among global health agencies and non-governmental organizations dedicated to reducing healthcare inequalities. Its empirical grounding and operational simplicity make it an attractive instrument for large-scale health surveys and community health assessments.

As the healthcare landscape evolves with emerging challenges such as aging populations, chronic disease burdens, and climate-induced health risks, tools like HABS will be instrumental in continuously appraising whether health systems are meeting the needs of all individuals regardless of their circumstances.

In summary, the Healthcare Access Barrier Scale emerges as a vital innovation with transformative potential for research, policy, and clinical practice. By enabling a systematic, evidence-based appraisal of access obstacles, this instrument paves the way for targeted, effective strategies to dismantle healthcare inequities and ultimately enhance health outcomes on a global scale. The scientific community and health stakeholders alike eagerly anticipate further validation studies and real-world applications that will realize HABS’s full promise.

Subject of Research: Development and validation of a tool to measure barriers to healthcare access.

Article Title: Development and validation of the healthcare access barrier scale (HABS).

Article References:
Hu, M., Jia, Y., Wang, X. et al. Development and validation of the healthcare access barrier scale (HABS). Int J Equity Health 24, 251 (2025). https://doi.org/10.1186/s12939-025-02624-x

Image Credits: AI Generated

Currently, Africa receives nearly three-quarters—71%—of the GFATM’s funding, a clear reflection of the continent’s immense health challenges and needs. However, this funding disparity is coupled with a meager 10% holding in voting rights on the Fund’s governing board. Such a skewed distribution of influence disrupts the equilibrium necessary for an accountable, responsive, and context-sensitive global health governance structure. As the article unfolds, it becomes clear that augmenting Africa’s representation by even a single governmental voting seat would yield substantive reforms. This is consistent with principles outlined in the Paris Declaration on Aid Effectiveness and other international frameworks urging more inclusive and equitable governance in global aid institutions.

The importance of this issue extends beyond mere symbolism. Enhanced African representation would directly impact the sustainability and efficacy of health interventions by aligning funding decisions with local realities and priorities. Robyn Hayes-Badenhorst, co-executive director of SHI and a co-author of the BMJ article, highlights how systemic minimization of African voices undermines the continent’s health sovereignty. She calls for a comprehensive overhaul of global health institutional architecture, moving beyond incremental governance changes to fundamentally redefining power balances that currently marginalize those most affected by global health policy decisions.

The urgency for reform is underscored by a recent funding crisis within the GFATM. In July 2025, the Fund announced a startling cut of US$1.43 billion from its current funding cycle, precipitated in part by the US government’s freeze and subsequent dismantling of USAID, along with further reductions in funding commitments from key donors such as Germany. This funding contraction threatens longstanding programs and exacerbates uncertainties, especially in African countries reliant on these resources. The cuts add a new layer of complexity to an already fragile health financing ecosystem, amplifying calls for more equitable governance structures that can navigate and mitigate such shocks.

In this climate of fiscal volatility, experts view the current crisis as a strategic inflection point. Professor Garrett Wallace Brown from the University of Leeds, who led the SHI research, frames the moment as a “window of opportunity” for radical reform within global health governance. He advocates for more representative strategic investments that promote African self-reliance, thereby reducing dependency on unstable external funding. The argument centers not only on increasing voting seats but also on recalibrating institutional focus towards sustainable domestic health financing and capacity building.

Domestic financing is spotlighted as an indispensable pillar of Africa’s health future. The continent’s persistent reliance on external aid hampers the development of robust local health systems capable of enduring shocks. However, domestic financing does not exist in isolation; it is intimately linked to the dynamics of global health governance and decision-making. Africa’s ability to mobilize resources internally is deeply influenced by the architecture of institutions like GFATM. As Magda Robalo, formerly chair of the Ethics and Governance Committee of the Global Fund, notes, meaningful reforms require not only shifts in representation but also enhanced technical, administrative, and leadership capacity within African states.

Despite the breadth of African health challenges spanning 47 countries, the continent is currently allocated only two voting seats on the GFATM board—one representing Eastern and Southern Africa, and one for Western and Central Africa. This arrangement dilutes the effectiveness of governance by forcing representatives to cover vast regions with diverse epidemiological, sociopolitical, and infrastructural contexts. Increasing the number of African governmental seats would alleviate this burden, enabling more focused advocacy and nuanced policy development that responds to region-specific needs. Dr. Lieve Fransen, a founding chair of the GFATM board, emphasizes that while adding one seat may appear incremental, such governance changes accumulate significant impact over time.

The BMJ Global Health article is bolstered by a complementary report coordinated by SHI, which presents empirical data underscoring the benefits of enhanced African involvement in global health governance. This research demonstrates a positive correlation between increased representation and improved ownership, contextualization, and aid sustainability. These factors collectively enhance aid effectiveness by ensuring that programs are aligned with the cultural, economic, and health system realities of recipient countries, thereby fostering more durable health outcomes.

Fundamental reforms must also address the accountability dynamics between donors and recipient states. Raising domestic funding is essential, as established by the Abuja Declaration’s target of allocating 15% of national budgets to health. Unfortunately, only a few African countries consistently meet this benchmark, limiting the pool of available resources and constraining the potential for co-financing arrangements that incentivize mutually beneficial donor-recipient partnerships. Additionally, just 57% of GFATM funds flow through public systems, a shortcoming that impedes effective capacity building and undermines health system strengthening efforts vital for long-term sustainability.

The article highlights that donors increasingly expect transparency, efficiency, and ownership from recipient countries, particularly as the global health funding environment becomes more precarious. Greater African representation on the GFATM board is viewed as a critical mechanism to future-proof the institution against external shocks and shifting donor priorities. Professor Brown asserts that reforms enhancing Africa-first governance are not only ethically necessary but are also pragmatic strategies to safeguard the enduring functionality of global health financing mechanisms.

The timing of this publication and accompanying report is particularly strategic. Released shortly before the G20 summit in South Africa, these works aim to influence global leaders as they deliberate commitments to promote inclusive governance and build resilient health systems. The ongoing debate around African representation is emblematic of broader questions related to equitable power sharing in international institutions, issues that resonate deeply in the context of post-pandemic health system recovery and reform worldwide.

Advocates like Hayes-Badenhorst emphasize the critical need for a loud and united African voice at forums like the G20 to press for the addition of at least one governmental voting seat on the GFATM board. Such an expansion is anticipated not merely as a procedural adjustment but as a foundational step toward establishing more just, responsive, and sustainable health governance architectures. Empowering African governments through stronger representation will enhance the alignment of health policies with local realities, encourage program longevity, and reduce chronic dependency on external aid actors.

This discourse on governance reform exemplifies a broader paradigm shift in global health, moving from top-down aid delivery toward participatory, equitable frameworks that acknowledge and address historical imbalances. Increasing African representation at decision-making tables is central to this transformation, potentially charting a course toward a more inclusive and effective global health system capable of meeting 21st-century challenges with resilience and shared responsibility.

Subject of Research: African representation and governance reforms in global health institutions, specifically the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Article Title: It is time to increase Africa’s governmental representation on the governing board of the global fund to fight AIDS, tuberculosis and malaria

News Publication Date: 15 September 2025

Web References:
https://gh.bmj.com/content/10/9/e018252
http://dx.doi.org/10.1136/bmjgh-2024-018252

Keywords: Public policy, Health care, Health equity, Geographic regions

From the early days of his medical career, Zhang demonstrated an unwavering focus on infectious diseases that disproportionately affect under-resourced regions. His choice to dedicate his efforts to Africa—a continent grappling with a heavy burden of communicable illnesses—stemmed from a recognition that global health security depends on collaborative, cross-continental solutions. This ethos propelled Zhang to bridge gaps between institutions, advocating for knowledge exchange, capacity building, and sustainable health interventions.

Technical collaboration under Zhang’s stewardship was characterized by the integration of cutting-edge Chinese medical technology with Africa’s diverse epidemiological landscape. Under his guidance, programs implemented advanced diagnostic tools and rapid response systems tailored to African settings. These technologies included multiplex polymerase chain reaction (PCR) platforms for simultaneous detection of pathogens, and portable imaging devices powered by artificial intelligence algorithms designed to aid frontline health workers in resource-limited environments.

Zhang’s work extended into the realm of vaccine research and development, utilizing genomic surveillance data to monitor pathogen evolution across different African regions. He championed the deployment of genomic sequencing technologies, enabling real-time tracking of viral mutations. This approach proved crucial during localized outbreaks of diseases such as Ebola, Lassa fever, and novel influenza strains, facilitating tailored vaccine design and timely immunization strategies.

Beyond technology, Zhang’s efforts laid significant groundwork for capacity enhancement among African healthcare professionals. He initiated training programs focusing on epidemiology, bioinformatics, and clinical management of infectious diseases. These programs, often conducted in partnership with African universities and research centers, utilized blended learning models combining in-person workshops with digital platforms to overcome geographical barriers.

A pivotal component of Zhang’s legacy is the establishment of a Sino-African Health Research Consortium, which institutionalized bilateral knowledge sharing and joint project implementation. This consortium has proven instrumental in conducting multicentric studies on neglected tropical diseases, drug-resistant infections, and chronic diseases emerging alongside infectious disease burdens. It also served as a forum for policy dialogue, helping align national strategies with regional health priorities.

Zhang’s vision of sustainable cooperation encompassed infrastructure development, leading to the establishment of several biosafety level-3 laboratories across African partner countries. These laboratories meet international safety standards for handling high-risk pathogens and are equipped for molecular diagnostics and vaccine development. This infrastructure significantly enhanced local capacity to conduct independent research and respond rapidly to emerging health threats.

Importantly, Zhang was a fervent advocate of data-driven policy making in global health. By promoting standardized data collection protocols and interoperable health information systems, his initiatives improved surveillance accuracy and enabled evidence-based decision making. The enhanced data infrastructure supported not only infectious disease control but also broader health system strengthening, facilitating resource allocation and epidemic preparedness.

Zhang’s influence extended to health diplomacy, where he skillfully navigated the complexities of international cooperation. His ability to build trust among diverse stakeholders—including government agencies, non-governmental organizations, and local communities—was key to sustaining multi-sectoral partnerships. His approach emphasized mutual respect, transparency, and shared goals, departing from traditional paradigms of donor-recipient dynamics toward genuine collaboration.

The culmination of Zhang’s lifelong dedication tragically arrived when he succumbed while responding to an outbreak in East Africa. However, his passing underscored the profound risks taken by frontline researchers and healthcare workers in epidemic settings, reinforcing global call-to-action for better protection measures and investment in frontline defense capacities.

Zhang’s legacy sheds light on the critical role of cross-border scientific collaboration in global health security. His model demonstrates that health challenges—unbound by geography—require coordinated international responses harnessing complementary strengths. The synthesis of Chinese technological innovation with African local expertise stands as a blueprint for the future of global health partnerships.

Moreover, Zhang’s life underscores the ethical imperatives central to global health research: humility, solidarity, and an unwavering focus on the most vulnerable populations. His contributions remind the scientific community that beyond data, technology, and policy, transformational change is driven by personal commitment and human connection.

In the context of China-Africa relations, Zhang’s work represents a new chapter that redefines the terms of engagement—moving beyond infrastructural investments to co-creation of knowledge, capacity, and systems resilient to future epidemics. The health cooperation mechanisms he established pave the way for enduring impact, addressing not only infectious diseases but also the broader determinants of health amid rapid societal changes in Africa.

As global health challenges continue to evolve with factors such as climate change, urbanization, and antimicrobial resistance, Zhang’s model of integrated, multi-disciplinary, and equitable cooperation serves as a beacon. It encourages the mobilization of scientific innovation alongside social accountability, ensuring that advancements translate into tangible health improvements for all.

In remembering Doctor Junqiao Zhang, the global health community honors a pioneer whose life and legacy are interwoven with the health futures of two continents. His work embodies the transformational potential of scientific diplomacy and patient-centered innovation, inspiring current and future generations to push the boundaries of what is achievable in global health.

Subject of Research: Health cooperation and infectious disease control between China and Africa, focusing on collaborative technologies, capacity building, and health diplomacy.

Article Title: The selfless sacrifice of doctor Junqiao Zhang: leaving a lasting legacy in China-Africa health cooperation.

Article References:

Xi, B., Li, H. The selfless sacrifice of doctor Junqiao Zhang: leaving a lasting legacy in China- Africa health cooperation.
glob health res policy 10, 39 (2025). https://doi.org/10.1186/s41256-025-00446-6

Image Credits: AI Generated

Global health, historically dominated by institutions from high-income countries often referred to as the Global North, remains entrenched within a “soft money” structure that profoundly influences both funding and ideological control. Soft money refers to funding that academics must continuously secure through competitive grants, rather than stable, institutional budget lines. This grant-dependent model underpins many research institutions’ financial health but paradoxically fuels systemic inequities by enabling Northern institutions to maintain disproportionate control over project agendas, resources, and global partnerships.

Krugman and Bayingana base their analysis on an interview series involving 30 faculty members from a prestigious unnamed School of Public Health in the United States. Their findings underscore a tension among faculty: while there is philosophical support for power shifting toward the Global South, practical anxieties loom large regarding job security and career continuities under a restructured funding model. This dilemma highlights the paradox wherein researchers’ livelihoods are interwoven with frameworks that inhibit the equitable redistribution of power the field ostensibly seeks to advance.

The “soft money” model intensifies precarity for global health researchers who often juggle multiple grants just to maintain their salaries—a practice one participant described evocatively as hunting for grants to survive. This relentless competition for funds diverts valuable intellectual and temporal resources away from the collaborative and impactful work necessary for meaningful global health interventions. Faculty testimonies reveal how frequently changing donor priorities force abrupt discontinuations of projects, compounding uncertainties for long-term global health partners in the Global South and undermining sustainable research relationships.

An in-depth exploration reveals that beyond abstract debates about decolonization and symbolic shifts in power, material systems such as funding mechanisms play a crucial role in reproducing structural imbalances. The financial necessity of securing grant overhead creates perverse incentives for institutions to maintain control over funding flows rather than devolve authority to Southern partners. This structural inertia perpetuates a cycle that benefits Northern actors financially and ideologically, complicating efforts to shift the paradigm toward genuine equity.

The concept of “ruinous solidarity” as introduced in the study is compelling and radical. It posits that for Global North institutions and researchers to enable authentic transformation, they must be willing to endure substantial losses—both institutional and personal. This willingness entails the potential destabilization of traditional career pathways and funding prestige in exchange for systemic change. Such an approach requires courage to embrace financial and professional uncertainty as a form of solidarity with Global South partners, signaling commitment beyond rhetoric.

The timing of this call is critical. In the context of retrenchment in US federal science budgets and a broader environment of constrained funding, the authors argue that the field is at a crossroads. The inclination for Northern institutions might be to double down on tried-and-tested mechanisms ensuring ongoing flows of “soft money.” However, perpetuation of these systems is likely to exacerbate the inequities and inefficiencies plaguing global health research, leading to burnout and diminishing impact across the sector.

Methodologically, Krugman and Bayingana’s qualitative anthropological and linguistic case study foregrounds narratives that are rarely heard publicly—those of faculty caught between moral imperatives and structural constraints. The researchers illuminate how these academic actors experience the system from within, describing emotional and practical challenges that obstruct transformative aspirations. The study’s rigor offers nuanced insights into how institutional logics operate and resist change, providing a vital empirical foundation for policymakers and advocates aiming to disentangle this complex web.

Significantly, the research highlights the dichotomy between symbolic power—visible shifts in rhetoric and representation—and material power embedded in financial structures. The authors compel us to recognize that symbolic gestures alone will be insufficient to dismantle the entrenched dominance of Northern institutions. Real-world reform requires financial restructuring that undermines dependency on Northern-led grant economies, thereby redistributing control and opportunity to Global South institutions and researchers.

This study invites a broad reconsideration of the academic industrial complex within global health. While many celebrate growing awareness around decolonizing the field, Krugman and Bayingana urge pragmatic reckoning with the financial architectures sustaining it. Unless Northern actors accept potential personal and institutional “ruin,” the perpetuation of “soft money” driven power asymmetries will likely continue unabated, thwarting efforts to foster truly equitable partnerships and sustainable global health improvements.

In extrapolating these findings to the broader global health community, we see an imperative for funders, institutions, and scholars to engage in frank dialogues about reconfiguring funding modalities. This includes exploring models that prioritize direct investment in Global South institutions, longer-term core funding, and mechanisms that decouple researcher salaries from grant acquisition pressures. Such avenues could help align incentives with the ethical commitments to equity that decolonizing global health demands.

Ultimately, the study’s insights resonate as a call to action—ending the era where financial survival trumps principled change requires courage and sacrifice at the heart of global health academia. The aspiration to shift from rhetoric to substantive transformation hinges on the willingness of privileged actors in Northern academic centers to embrace “ruinous solidarity,” creating a pathway for justice that transcends comfort and conventional norms.

Subject of Research: Financial and institutional dynamics underpinning power inequalities in global health academic structures

Article Title: Soft money, hard power: Mapping the material contingencies of change in global health academic structures

News Publication Date: 28-May-2025

Web References: http://dx.doi.org/10.1371/journal.pgph.0004622

References: Krugman DW, Bayingana A (2025) Soft money, hard power: Mapping the material contingencies of change in global health academic structures. PLOS Glob Public Health 5(5): e0004622.

Image Credits: The City of Toronto

Keywords: global health, decolonization, soft money, research funding, institutional power, Global North, Global South, grant dependency, academic precarity, ruinous solidarity

With approximately 400 million individuals in need of medical oxygen each year, the data highlights a staggering reality: over five billion people, equivalent to 60% of the world’s population, remain without reliable access to safe and affordable medical oxygen services. This inequity poses a significant challenge for healthcare systems, especially in low- and middle-income countries (LMICs), where the need is most acute and options are severely limited. Without appropriate measures, countless lives are at risk, reinforcing the call for immediate and strategic action to fill this gap.

Dr. Hamish Graham, a co-author of the report from the Murdoch Children’s Research Institute, emphasizes the role of oxygen at all levels of healthcare for individuals suffering from both chronic and acute conditions. His commentary reveals that previous efforts, particularly during the pandemic era, focused primarily on augmenting the supply side by producing more oxygen-generating equipment. However, this approach failed to address the underlying challenges related to distribution, maintenance, and safe administration, which are equally crucial for effective oxygen delivery.

In addressing the medical oxygen crisis, Dr. Graham advocates for strategic investments in national oxygen plans that would not only enhance the healthcare infrastructure but also promote the routine use of pulse oximeters. These small devices measure blood oxygen levels and are therefore essential for determining the need for oxygen therapy in patients. As it stands, these devices are found in just over half of general hospitals in LMICs, and their availability often suffers from regular shortages and malfunctioning equipment. The inequitable access further complicates healthcare delivery, with pulse oximetry rarely being performed on patients in primary care settings, particularly in remote and rural areas.

The report reveals that a significant portion of the population affected by respiratory ailments resides in Sub-Saharan Africa, where healthcare facilities frequently lack the necessary resources to provide adequate oxygen care. This alarming scenario calls for urgent action to ensure that affordable and high-quality pulse oximeters are broadly accessible to healthcare providers throughout these underserved regions. According to Dr. Graham, the pivotal point falls on both national governments and health organizations to innovate and devise suitable mechanisms that facilitate the integration of medical oxygen into standard treatment protocols across all healthcare settings.

Recognizing the importance of incorporating medical oxygen into national health strategies, the Commission stresses the need for cross-sector collaboration. Governments are urged to engage with public and private sector stakeholders, including representatives from health, education, industry, energy, and transportation, to devise a coherent governance structure that supports the Global Oxygen Alliance (GO₂AL) framework. Such collaboration would enable enhanced resource mobilization and better alignment of oxygen services, ultimately benefiting communities in need.

The report articulates key findings that illustrate the magnitude of the medical oxygen need globally. Annually, approximately 374 million people require oxygen, comprising a vast array of patients afflicted with acute and chronic health conditions. Additionally, amid pandemic-related investments, stark gaps in oxygen access persist, with less than 33% of the affected population in LMICs receiving the oxygen they need for acute health situations. This disparity further necessitates targeted investments, which the report estimates to involve six point eight billion US dollars per year to effectively address the access gap.

Furthermore, it points out that less than thirty countries have so far established National Medical Oxygen Plans. The recommendation is clear: governments should aim for the development of such plans by 2030. These plans are essential for facilitating investment and ensuring effective coordination in the delivery of medical oxygen services.

The report also tackles the significant operational aspect of oxygen systems, stating that their designs must be contextualized to meet local healthcare demands while maintaining affordability for all patients involved. There is no universally applicable model for medical oxygen systems—adaptations are necessary to suit local conditions and prioritize tailored solutions. Emphasizing pulse oximetry, the document advocates for its integration into clinical guidelines and education at all healthcare levels, reinforcing the idea that pulse oximeters are the gateway to ensuring safe and effective oxygen therapy delivery.

The Commission highlights the pressing need for revitalized engagements between the medical oxygen industry, national governments, and global health agencies. It calls for corporate partners to establish specific targets for increased oxygen access and to track their progress transparently, similar to mechanisms in place for the pharmaceutical industry where accountability metrics are regularly evaluated.

To enable informed decision-making, the availability of accurate and timely data regarding oxygen systems is essential. The report introduces innovative tools, like the Oxygen Coverage Indicators and the Access to Medical Oxygen Scorecard (ATMO₂S), both of which would empower governments to plan their national oxygen strategies effectively, while concurrently tracking progress in alignment with the World Health Organization’s Oxygen Resolution.

The global medical oxygen crisis poses a considerable threat to health outcomes, particularly in an era marked by increased vulnerability to respiratory diseases and rising health inequities. This recently published report acts as a clarion call for action, signaling that the time to address these gaps has never been more urgent. As the world continues to grapple with the long-term impacts of both the COVID-19 pandemic and existing healthcare disparities, the insights from the Lancet Global Health Commission report will prove invaluable in guiding future investments and interventions aimed at securing medical oxygen access for all.

By strategically investing in infrastructure, advocating for collaborative partnerships across multiple sectors, and fostering innovations in data collection and analysis, stakeholders can work together to reshape the landscape of medical oxygen access, ultimately contributing to the saving of millions of lives annually while advancing global health equity.

Subject of Research: Medical Oxygen Access and Inequities
Article Title: Reducing Global Inequities in Medical Oxygen Access: The Lancet Global Health Commission on Medical Oxygen Security
News Publication Date: February 17, 2025
Web References: Lancet Global Health Commission on Medical Oxygen Security
References: Hamish R Graham et al., Reducing global inequities in medical oxygen access
Image Credits: Murdoch Children’s Research Institute

Keywords: Medical Oxygen, Global Health, Health Equity, Pandemic Preparedness, Pulse Oximeters, Low and Middle-Income Countries